The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface
- PMID: 1304876
- PMCID: PMC2142082
- DOI: 10.1002/pro.5560010115
The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface
Abstract
The histidine-glycine-rich region of the light chain of cleaved high molecular weight kininogen (HK) is thought to be responsible for binding to negatively charged surfaces and initiation of the intrinsic coagulation, fibrinolytic, and kinin-forming systems. However, the specifically required amino acid sequences have not been delineated. An IgG fraction of a monoclonal antibody (MAb) C11C1 to the HK light chain was shown to inhibit by 66% the coagulant activity and by 57% the binding of HK to the anionic surface of kaolin at a concentration of 1.5 microM and 27 microM, respectively. Proteolytic fragments of HK were produced by successive digestion with human plasma kallikrein and factor XIa (FXIa). Those polypeptides that bound tightly (Kd = 0.77 nM) to a C11C1 affinity column were eluted at pH 3.0 and purified by membrane filtration. On 15% SDS polyacrylamide electrophoresis, the approximate M(r) was 7.3 kDa (range 6.2-8.1 kDa). Based on N-terminal sequencing, this polypeptide (1(2)), which extends from the histidine residue 459 to a lysine at position 505, 509, 511, 512, 515, or 520, inhibits by 50% the coagulant activity expressed by HK at a concentration of 22 microM. The synthetic peptide HGLGHGH representing the N-terminal of the 1(2)) fragment was synthesized, tested, and found at 4 mM to inhibit the procoagulant activity of HK 50%. A synthetic heptadecapeptide, HGLGHGHEQQHGLGHGH (residues 459-475) included within the 1(2) fragment, and with the ability to bind zinc, inhibited 50% of the HK coagulant activity at a concentration of 325 microM in the absence and presence of added Zn2+ (30 microM). The specific binding of 125I-HK to a negatively charged surface (kaolin) was inhibited 50% by unlabeled HK (5 microM). HGLGHGH, at a concentration of 7.0 mM, inhibited the binding to kaolin by 50%. The heptadecapeptide inhibited the specific binding of 125I-HK to kaolin by 50%, at a concentration of 2.3 mM, in the absence of Zn2+. In contrast, when Zn2+ was added, the concentration to achieve 50% inhibition decreased to 630 microM, indicating that Zn2+ was required to attain a favorable conformation for binding. Moreover, the 1(2) fragment was found to inhibit 50% of the 125I-HK binding to kaolin at a concentration of 380 microM. These results suggest that residues contained within the 1(2) fragment, notably HGLGHGHEQQHGLGHGH, serves as a primary structural feature for binding to a negatively charged surface.
Similar articles
-
Deletion mutagenesis of high molecular weight kininogen light chain. Identification of two anionic surface binding subdomains.J Biol Chem. 1993 Feb 5;268(4):2486-92. J Biol Chem. 1993. PMID: 8428925
-
Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.J Clin Invest. 1984 Apr;73(4):954-62. doi: 10.1172/JCI111319. J Clin Invest. 1984. PMID: 6561202 Free PMC article.
-
Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity.Blood. 1989 Aug 1;74(2):695-702. Blood. 1989. PMID: 2752143
-
Role of the light chain of high molecular weight kininogen in adhesion, cell-associated proteolysis and angiogenesis.Biol Chem. 2001 Jan;382(1):65-70. doi: 10.1515/BC.2001.011. Biol Chem. 2001. PMID: 11258675 Review.
-
Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease.Immunopharmacology. 1999 Sep;43(2-3):203-10. doi: 10.1016/s0162-3109(99)00136-8. Immunopharmacology. 1999. PMID: 10596854 Review.
Cited by
-
Staphylococcus aureus induces release of bradykinin in human plasma.Infect Immun. 2001 Jun;69(6):3877-82. doi: 10.1128/IAI.69.6.3877-3882.2001. Infect Immun. 2001. PMID: 11349054 Free PMC article.
-
Polyphosphate, Zn2+ and high molecular weight kininogen modulate individual reactions of the contact pathway of blood clotting.J Thromb Haemost. 2019 Dec;17(12):2131-2140. doi: 10.1111/jth.14612. Epub 2019 Sep 18. J Thromb Haemost. 2019. PMID: 31420909 Free PMC article.
-
Human mast cell tryptase isoforms: separation and examination of substrate-specificity differences.Biochem J. 1995 Apr 15;307 ( Pt 2)(Pt 2):341-6. doi: 10.1042/bj3070341. Biochem J. 1995. PMID: 7733867 Free PMC article.
-
Antifungal activities of peptides derived from domain 5 of high-molecular-weight kininogen.Int J Pept. 2011;2011:761037. doi: 10.1155/2011/761037. Epub 2011 Sep 14. Int J Pept. 2011. PMID: 21941573 Free PMC article.
-
Profiling of Cross-Functional Peptidases Regulated Circulating Peptides in BRCA1 Mutant Breast Cancer.J Proteome Res. 2016 May 6;15(5):1534-45. doi: 10.1021/acs.jproteome.6b00010. Epub 2016 Apr 26. J Proteome Res. 2016. PMID: 27058005 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources